The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, today reaffirmed 2025 guidance and provided its preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback